Search Results

Impact of New Variants | Marta Boffito, MD, PhD, FRCP

Impact of New Variants | Marta Boffito, MD, PhD, FRCP

Novel Drug Delivery Systems | Marta Boffito, MD, PhD, FRCP

Novel Drug Delivery Systems | Marta Boffito, MD, PhD, FRCP

Pharmacokinetics of LA CAB - Marta Boffito, MD, PhD, FRCP

Pharmacokinetics of LA CAB - Marta Boffito, MD, PhD, FRCP

Clinical Pharmacology of Long-Acting Therapy - Marta Boffito, MD, PhD, FRCP

Clinical Pharmacology of Long-Acting Therapy - Marta Boffito, MD, PhD, FRCP

Integrating Science Into The Clinic: Current and Future Use of ... | Marta Boffito, MD, PhD, FRCP

Integrating Science Into The Clinic: Current and Future Use of ... | Marta Boffito, MD, PhD, FRCP

Pharmacological Considerations in the Complex HIV Patient | Marta Boffito MD, PhD, FRCP

Pharmacological Considerations in the Complex HIV Patient | Marta Boffito MD, PhD, FRCP

HIV Over-50-Years Clinic in London | Marta Boffito, MD, PhD, FRCP

HIV Over-50-Years Clinic in London | Marta Boffito, MD, PhD, FRCP

Pharmacology of Injectable ART & Implications for Toxicity & Resistance-Marta Boffito, MD, PhD, FRCP

Pharmacology of Injectable ART & Implications for Toxicity & Resistance-Marta Boffito, MD, PhD, FRCP

Use of INSTI in Patients With Comorbidities and Polypharmacy - Marta Boffito, MD, PhD, FRCP

Use of INSTI in Patients With Comorbidities and Polypharmacy - Marta Boffito, MD, PhD, FRCP

Clinical case presentation | Marta Boffito, MD, PhD, FRCP

Clinical case presentation | Marta Boffito, MD, PhD, FRCP

Pharmacological Considerations When Choosing Optimal Treatment Regimen - Marta Boffito

Pharmacological Considerations When Choosing Optimal Treatment Regimen - Marta Boffito

Pharmacological Considerations in Optimal Integrase Inhibitors Clinical Care | Marta Boffito

Pharmacological Considerations in Optimal Integrase Inhibitors Clinical Care | Marta Boffito